Search

everythinglearnresearchcommunity

for

Search:↓

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

PRP treatment improves hair density and thickness for alopecia, but needs more research.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.

Most skin changes during pregnancy are harmless and moles don't significantly change, but many women experience pigmentation changes due to hormones and sun exposure.

PRP growth factor concentrations vary, no significant hair growth difference found.

Minoxidil effectively promotes hair regrowth in younger patients with small balding areas.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Adding cells to fat grafts improves hair regrowth in early baldness, but effects lessen over time.

High-quality photos help track hair growth progress in androgenetic alopecia patients.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Platelet-rich plasma may improve vitiligo treatment when used with phototherapy.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Topical booster improves hair loss treatment effectiveness.